Search This Blog

Tuesday, August 13, 2019

Adaptive Biotechnologies EPS of -$1.23

Adaptive Biotechnologies (NASDAQ:ADPT): Q2 EPS of -$1.23 may not be comparable to consensus of -$0.14.
Revenue of $22.14M (+91.4% Y/Y) beats by $2.75M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)